BN Business News
Add your company to Business Communicator →

Market regulation · 25/02/2016

Hikma Pharmaceuticals PLC and C.H. Boehringer Sohn AG & Co. KG Reach Settlement Over Allegations of Unfair Competition

Hikma Pharmaceuticals PLC and C.H. Boehringer Sohn AG & Co. KG have agreed to a consent settlement, which resolves allegations of violating federal law that prohibits unfair business practices, as outlined in a draft complaint and detailed in an accompanying analysis.

Original source language: Federal Register — Federal Trade CommissionOpen original release →

Explore insights